"To Ερρίκος Ντυνάν Hospital Center αποτελεί ένα από τα πλέον σύγχρονα νοσηλευτικά κέντρα όχι μόνον εντός της ελληνικής επικράτειας, αλλά στην ευρύτερη περιοχή της Νοτιοανατολικής Ευρώπης. Στις εγκαταστάσεις του, που εκτείνονται σε 54 χιλιάδες τ.μ., αναπτύσσονται ιατρικά τμήματα, εξειδικευμένα κέντρα και εξωτερικά ιατρεία όλων των ειδικοτήτων, πλήρως εξοπλισμένα με μηχανήματα τελευταίας τεχνολογίας. Στελεχώνεται με άρτια εκπαιδευμένο διοικητικό και νοσηλευτικό προσωπικό, κορυφαίους ιατρούς αποκλειστικής απασχόλησης, καθώς και από πλήθος διακεκριμένων εξωτερικών συνεργατών. Διαθέτει 462 κλίνες νοσηλείας, (μεταξύ των οποίων 38 κλίνες ΜΕΘ και 20 κλίνες ΜΤΝ) και 25 σύγχρονες χειρουργικές αίθουσες. Έχει σύμβαση με τον ΕΟΠΥΥ"

During the past decade, Henry Dunant Hospital Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Henry Dunant Hospital Center" #1 sponsor was "Amgen" with 5 trials, followed by "Hellenic Cooperative Oncology Group" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Cidara Therapeutics Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Dunant Hospital Center" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Care Across Ltd" with 1 trials as a collaborator, "Everest Medicines" with 1 trials as a collaborator and "Merck Healthcare Germany GmbH, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Henry Dunant Hospital Center" are "Atrial Fibrillation" (2 trials), "Advanced Renal Cell Carcinoma" (1 trials), "Breast Cancer" (1 trials), "Candidemia" (1 trials) and "Carcinoma, Renal Cell" (1 trials). Many other conditions were trialed in "Henry Dunant Hospital Center" in a lesser frequency.

Most popular intervention types in "Henry Dunant Hospital Center" are "Drug" (11 trials), "Biological" (2 trials), "Device" (2 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (3 trials), "Vinflunine" (2 trials), "AMG 510" (1 trials), "Albumin (Human) 25%, United States Pharmacopeia (USP)" (1 trials) and "Anti PD-1/L1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Henry Dunant Hospital Center" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Henry Dunant Hospital Center". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Henry Dunant Hospital Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Dunant Hospital Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Henry Dunant Hospital Center has several departments that took part in Clinical trials: "Henri Dunant Hospital; Oncology Dept." - 2 trials